FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3195966818> ?p ?o ?g. }

• W3195966818 endingPage "e234" @default.
• W3195966818 startingPage "e219" @default.
• W3195966818 abstract "A joint American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology panel convened to develop a focused update of the American Society of Clinical Oncology guideline concerning use of postmastectomy radiotherapy (PMRT). Methods A recent systematic literature review by Cancer Care Ontario provided the primary evidentiary basis. The joint panel also reviewed targeted literature searches to identify new, potentially practice-changing data. Recommendations The panel unanimously agreed that available evidence shows that PMRT reduces the risks of locoregional failure (LRF), any recurrence, and breast cancer mortality for patients with T1-2 breast cancer with one to three positive axillary nodes. However, some subsets of these patients are likely to have such a low risk of LRF that the absolute benefit of PMRT is outweighed by its potential toxicities. In addition, the acceptable ratio of benefit to toxicity varies among patients and physicians. Thus, the decision to recommend PMRT requires a great deal of clinical judgment. The panel agreed clinicians making such recommendations for individual patients should consider factors that may decrease the risk of LRF, attenuate the benefit of reduced breast cancer–specific mortality, and/or increase risk of complications resulting from PMRT. When clinicians and patients elect to omit axillary dissection after a positive sentinel node biopsy, the panel recommends that these patients receive PMRT only if there is already sufficient information to justify its use without needing to know additional axillary nodes are involved. Patients with axillary nodal involvement after neoadjuvant systemic therapy should receive PMRT. The panel recommends treatment generally be administered to both the internal mammary nodes and the supraclavicular-axillary apical nodes in addition to the chest wall or reconstructed breast. A joint American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology panel convened to develop a focused update of the American Society of Clinical Oncology guideline concerning use of postmastectomy radiotherapy (PMRT). A recent systematic literature review by Cancer Care Ontario provided the primary evidentiary basis. The joint panel also reviewed targeted literature searches to identify new, potentially practice-changing data. The panel unanimously agreed that available evidence shows that PMRT reduces the risks of locoregional failure (LRF), any recurrence, and breast cancer mortality for patients with T1-2 breast cancer with one to three positive axillary nodes. However, some subsets of these patients are likely to have such a low risk of LRF that the absolute benefit of PMRT is outweighed by its potential toxicities. In addition, the acceptable ratio of benefit to toxicity varies among patients and physicians. Thus, the decision to recommend PMRT requires a great deal of clinical judgment. The panel agreed clinicians making such recommendations for individual patients should consider factors that may decrease the risk of LRF, attenuate the benefit of reduced breast cancer–specific mortality, and/or increase risk of complications resulting from PMRT. When clinicians and patients elect to omit axillary dissection after a positive sentinel node biopsy, the panel recommends that these patients receive PMRT only if there is already sufficient information to justify its use without needing to know additional axillary nodes are involved. Patients with axillary nodal involvement after neoadjuvant systemic therapy should receive PMRT. The panel recommends treatment generally be administered to both the internal mammary nodes and the supraclavicular-axillary apical nodes in addition to the chest wall or reconstructed breast." @default.
• W3195966818 created "2021-08-30" @default.
• W3195966818 creator A5002193653 @default.
• W3195966818 creator A5009038938 @default.
• W3195966818 creator A5013474509 @default.
• W3195966818 creator A5016887928 @default.
• W3195966818 creator A5019007552 @default.
• W3195966818 creator A5032886944 @default.
• W3195966818 creator A5034694632 @default.
• W3195966818 creator A5044329891 @default.
• W3195966818 creator A5046031005 @default.
• W3195966818 creator A5047713528 @default.
• W3195966818 creator A5048222996 @default.
• W3195966818 creator A5052023186 @default.
• W3195966818 creator A5052395460 @default.
• W3195966818 creator A5053489698 @default.
• W3195966818 creator A5066769011 @default.
• W3195966818 creator A5081575792 @default.
• W3195966818 creator A5088301461 @default.
• W3195966818 date "2016-11-01" @default.
• W3195966818 modified "2023-10-01" @default.
• W3195966818 title "Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update" @default.
• W3195966818 cites W1469292490 @default.
• W3195966818 cites W1770259999 @default.
• W3195966818 cites W1865004367 @default.
• W3195966818 cites W1948261638 @default.
• W3195966818 cites W1968438702 @default.
• W3195966818 cites W1974963414 @default.
• W3195966818 cites W1975289748 @default.
• W3195966818 cites W1986064152 @default.
• W3195966818 cites W1986666594 @default.
• W3195966818 cites W1995679745 @default.
• W3195966818 cites W1997542577 @default.
• W3195966818 cites W1997950192 @default.
• W3195966818 cites W2003861755 @default.
• W3195966818 cites W2005116074 @default.
• W3195966818 cites W2012345480 @default.
• W3195966818 cites W2013305796 @default.
• W3195966818 cites W2015133952 @default.
• W3195966818 cites W2021493967 @default.
• W3195966818 cites W2024160646 @default.
• W3195966818 cites W2034800492 @default.
• W3195966818 cites W2046826982 @default.
• W3195966818 cites W2050659321 @default.
• W3195966818 cites W2052052878 @default.
• W3195966818 cites W2060250348 @default.
• W3195966818 cites W2062298610 @default.
• W3195966818 cites W2066664467 @default.
• W3195966818 cites W2069383559 @default.
• W3195966818 cites W2070281077 @default.
• W3195966818 cites W2080190730 @default.
• W3195966818 cites W2085503913 @default.
• W3195966818 cites W2087263485 @default.
• W3195966818 cites W2092950740 @default.
• W3195966818 cites W2096785769 @default.
• W3195966818 cites W2099372168 @default.
• W3195966818 cites W2099821036 @default.
• W3195966818 cites W2100025800 @default.
• W3195966818 cites W2102607007 @default.
• W3195966818 cites W2104157423 @default.
• W3195966818 cites W2105913036 @default.
• W3195966818 cites W2107073127 @default.
• W3195966818 cites W2109320466 @default.
• W3195966818 cites W2111549782 @default.
• W3195966818 cites W2114349652 @default.
• W3195966818 cites W2114794378 @default.
• W3195966818 cites W2122761438 @default.
• W3195966818 cites W2123426681 @default.
• W3195966818 cites W2126446157 @default.
• W3195966818 cites W2129825983 @default.
• W3195966818 cites W2130840692 @default.
• W3195966818 cites W2133264822 @default.
• W3195966818 cites W2133865595 @default.
• W3195966818 cites W2135084486 @default.
• W3195966818 cites W2137829275 @default.
• W3195966818 cites W2138652241 @default.
• W3195966818 cites W2140978771 @default.
• W3195966818 cites W2148230878 @default.
• W3195966818 cites W2149741780 @default.
• W3195966818 cites W2154375587 @default.
• W3195966818 cites W2154889318 @default.
• W3195966818 cites W2155173264 @default.
• W3195966818 cites W2158615473 @default.
• W3195966818 cites W2158665686 @default.
• W3195966818 cites W2161871715 @default.
• W3195966818 cites W2168517539 @default.
• W3195966818 cites W2170058000 @default.
• W3195966818 cites W2176010689 @default.
• W3195966818 cites W2177229741 @default.
• W3195966818 cites W2921131656 @default.
• W3195966818 cites W993406450 @default.
• W3195966818 doi "https://doi.org/10.1016/j.prro.2016.08.009" @default.
• W3195966818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27659727" @default.
• W3195966818 hasPublicationYear "2016" @default.
• W3195966818 type Work @default.
• W3195966818 sameAs 3195966818 @default.
• W3195966818 citedByCount "121" @default.
• W3195966818 countsByYear W31959668182017 @default.

• next